chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokinesia, Limb discomfort
Clinical narrative: Left arm felt heavy; Unable to operate his left arm freely; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Left arm felt heavy) and HYPOKINESIA (Unable to operate his left arm freely) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and W2C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-May-2021, the patient experienced LIMB DISCOMFORT (Left arm felt heavy) and HYPOKINESIA (Unable to operate his left arm freely). At the time of the report, LIMB DISCOMFORT (Left arm felt heavy) and HYPOKINESIA (Unable to operate his left arm freely) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Product dose omission issue, Vomiting
Clinical narrative: diarrhea; vomiting; has not received 2nd dose. first dose administered 27Mar2021; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomiting), DIARRHOEA (diarrhea) and PRODUCT DOSE OMISSION ISSUE (has not received 2nd dose. first dose administered 27Mar2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not received 2nd dose. first dose administered 27Mar2021). On an unknown date, the patient experienced VOMITING (vomiting) and DIARRHOEA (diarrhea). At the time of the report, VOMITING (vomiting) and DIARRHOEA (diarrhea) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (has not received 2nd dose. first dose administered 27Mar2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information, if any, was not provided by the reporter. Treatment information, if any, was not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: The first shot was given 7 weeks ago. So we Missed the one month time frame; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (The first shot was given 7 weeks ago. So we Missed the one month time frame) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (The first shot was given 7 weeks ago. So we Missed the one month time frame). On 09-Jul-2021, PRODUCT DOSE OMISSION ISSUE (The first shot was given 7 weeks ago. So we Missed the one month time frame) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information, if any, was not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patients received vaccine after allowed expiry at room temperature; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received vaccine after allowed expiry at room temperature) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received vaccine after allowed expiry at room temperature). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received vaccine after allowed expiry at room temperature) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information, if any, was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up received on 27-Jul-2021 and contains no new information.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Muscle strain, Myalgia
Clinical narrative: "Strained" muscles; Sore muscles - tendon type; Fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of MUSCLE STRAIN ("Strained" muscles), MYALGIA (Sore muscles - tendon type) and FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE STRAIN ("Strained" muscles), MYALGIA (Sore muscles - tendon type) and FATIGUE (Fatigue). At the time of the report, MUSCLE STRAIN ("Strained" muscles), MYALGIA (Sore muscles - tendon type) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Blunted affect
Clinical narrative: may have a blunted immune response to the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of BLUNTED AFFECT (may have a blunted immune response to the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Chronic leukemia.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLUNTED AFFECT (may have a blunted immune response to the vaccine). At the time of the report, BLUNTED AFFECT (may have a blunted immune response to the vaccine) outcome was unknown.            Concomitant product information, if any, was not provided by the reporter. Treatment information, if any, was not provided by the reporter.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination complication
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (experienced symptoms) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced vaccination complication (experienced symptoms). At the time of the report, vaccination complication (experienced symptoms) outcome: unknown. Diagnostic results: On an unknown date, SARS-CoV-2 test: positive. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired Moderna vaccines that were given to 7 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccines that were given to 7 patients) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20a) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccines that were given to 7 patients). On 09-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Expired Moderna vaccines that were given to 7 patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Nurse stated the Moderna vaccine was in refrigerator at 37F. Then it was moved from freezer on 6-17-2021. There was no visual impact or cloudiness and the vials were still clear with only one 10mL of the Moderna vaccine vial affected.  No concomitant medication was provided.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up document is received patient demographic details, anatomical location of vaccine administration is added.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Mental status changes, Mood altered, Muscle twitching
Clinical narrative: Weakness; Mental changes; Mood changes; continuous side effects; Fatigue; Pressure on hips; Ringing in the ears; Uncontrollable muscle twitches; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Pressure on hips), TINNITUS (Ringing in the ears), MUSCLE TWITCHING (Uncontrollable muscle twitches), ASTHENIA (Weakness) and MENTAL STATUS CHANGES (Mental changes) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 03A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (Pressure on hips), TINNITUS (Ringing in the ears) and MUSCLE TWITCHING (Uncontrollable muscle twitches). On an unknown date, the patient experienced ASTHENIA (Weakness), MENTAL STATUS CHANGES (Mental changes), MOOD ALTERED (Mood changes), VACCINATION COMPLICATION (continuous side effects) and FATIGUE (Fatigue). At the time of the report, MUSCULOSKELETAL DISCOMFORT (Pressure on hips), TINNITUS (Ringing in the ears), MUSCLE TWITCHING (Uncontrollable muscle twitches), ASTHENIA (Weakness), MENTAL STATUS CHANGES (Mental changes), MOOD ALTERED (Mood changes), VACCINATION COMPLICATION (continuous side effects) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant Followup received : events were added and patient demographics were updated.Fatigue,Weakness,Mental changes,Mood changes, Continous side effects were the events and the outcome is unknown. Date of birth is updated in demographics.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal discomfort, Tinnitus, Vaccination complication
Clinical narrative: Weakness; Mental changes; Mood changes; continuous side effects; Fatigue; Pressure on hips; Ringing in the ears; Uncontrollable muscle twitches; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (Pressure on hips), TINNITUS (Ringing in the ears), MUSCLE TWITCHING (Uncontrollable muscle twitches), ASTHENIA (Weakness) and MENTAL STATUS CHANGES (Mental changes) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 03A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (Pressure on hips), TINNITUS (Ringing in the ears) and MUSCLE TWITCHING (Uncontrollable muscle twitches). On an unknown date, the patient experienced ASTHENIA (Weakness), MENTAL STATUS CHANGES (Mental changes), MOOD ALTERED (Mood changes), VACCINATION COMPLICATION (continuous side effects) and FATIGUE (Fatigue). At the time of the report, MUSCULOSKELETAL DISCOMFORT (Pressure on hips), TINNITUS (Ringing in the ears), MUSCLE TWITCHING (Uncontrollable muscle twitches), ASTHENIA (Weakness), MENTAL STATUS CHANGES (Mental changes), MOOD ALTERED (Mood changes), VACCINATION COMPLICATION (continuous side effects) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant Followup received : events were added and patient demographics were updated.Fatigue,Weakness,Mental changes,Mood changes, Continous side effects were the events and the outcome is unknown. Date of birth is updated in demographics.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received  the second dose 77 days after the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received  the second dose 77 days after the first dose) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 009D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received  the second dose 77 days after the first dose). On 09-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received  the second dose 77 days after the first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information, if any, was not provided by the reporter.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Sore throat; Runny nose; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose) and COUGH (Coughing) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jul-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose) and COUGH (Coughing). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) for Adverse event, at a dose of 1 dosage form and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Adverse event, at a dose of 1 dosage form. At the time of the report, OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Runny nose) and COUGH (Coughing) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Cough, Fatigue, Myalgia
Clinical narrative: lost of taste; loss of smell; congestion; cough; body aches; fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion) and COUGH (cough) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PROPRANOLOL for an unknown indication.    On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Jun-2021, the patient experienced AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion), COUGH (cough), MYALGIA (body aches) and FATIGUE (fatigue). The patient was treated with GUAIFENESIN (MUCINEX) at a dose of 1 dosage form; IBUPROFEN at a dose of 1 dosage form; BENZONATATE at a dose of 1 dosage form and PROMETHAZINE at a dose of 1 dosage form. On 27-Apr-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion), COUGH (cough), MYALGIA (body aches) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jul-2021, SARS-CoV-2 test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-253081 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Pain in extremity, SARS-CoV-2 test
Clinical narrative: lost of taste; loss of smell; congestion; cough; body aches; fatigue; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion) and COUGH (cough) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PROPRANOLOL for an unknown indication.    On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Jun-2021, the patient experienced AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion), COUGH (cough), MYALGIA (body aches) and FATIGUE (fatigue). The patient was treated with GUAIFENESIN (MUCINEX) at a dose of 1 dosage form; IBUPROFEN at a dose of 1 dosage form; BENZONATATE at a dose of 1 dosage form and PROMETHAZINE at a dose of 1 dosage form. On 27-Apr-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, AGEUSIA (lost of taste), ANOSMIA (loss of smell), NASAL CONGESTION (congestion), COUGH (cough), MYALGIA (body aches) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jul-2021, SARS-CoV-2 test: positive (Positive) positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-253081 (Patient Link).
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lethargy, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: I was lethargic for a day or 2 after injection; Arm soreness at injection site; Extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm soreness at injection site), FATIGUE (Extreme fatigue) and LETHARGY (I was lethargic for a day or 2 after injection) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Dust allergy, Allergy to molds and Seasonal allergy. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC R), SODIUM CHLORIDE, XYLITOL (SALINASE MAX) and MULTIVITAMINS [VITAMINS NOS] for Product used for unknown indication, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE (TRUVADA), VITAMIN D NOS, VITAMIN C [ASCORBIC ACID], ZINC and BARLEY for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness at injection site) and FATIGUE (Extreme fatigue). On an unknown date, the patient experienced LETHARGY (I was lethargic for a day or 2 after injection). At the time of the report, VACCINATION SITE PAIN (Arm soreness at injection site), FATIGUE (Extreme fatigue) and LETHARGY (I was lethargic for a day or 2 after injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jul-2021, SARS-CoV-2 test: positive (Positive) positive for covid 19.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Green with varying strength is used by patient as concomitant drug Treatment information was not provided On 15th July 2021 patient done his rapid and PCR test   This case was linked to MOD-2021-254109 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Aug-2021: Significant Follow Up Appended- Event added
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: dose given was beyond the use date (BUD) of 8July2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose given was beyond the use date (BUD) of 8July2021) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose given was beyond the use date (BUD) of 8July2021). On 09-Jul-2021, EXPIRED PRODUCT ADMINISTERED (dose given was beyond the use date (BUD) of 8July2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered EXPIRED PRODUCT ADMINISTERED (dose given was beyond the use date (BUD) of 8July2021) to be not applicable.    Concomitant medications were not reported.   This case was linked to MOD21-119255, MOD21-119243 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Updated query has been received from Safety and mentioned in inarrative. On 14-Jul-2021: Follow up document received on 14-UL-2021 and contains No New Information; Sender's Comments: This report refers to a case of Expired vaccine use for mRNA-1273, lot 051C21A with no associated AEs. According to Regulatory Authority's module this is an invalid case.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concomitant products included PROPRANOLOL for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced MYALGIA (sore arm). On 28-Mar-2021, MYALGIA (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information were provided.   This case was linked to MOD-2021-253071 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Paraesthesia, Rash macular, Vaccination site swelling
Clinical narrative: A red ball swollen, it's warm on the site; Red ball swollen, it's warm on the site; Tingling; Numb; Tingling on the arm; Pain in the arm; Red spot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (A red ball swollen, it's warm on the site), PARAESTHESIA (Tingling), HYPOAESTHESIA (Numb), PARAESTHESIA (Tingling on the arm) and PAIN IN EXTREMITY (Pain in the arm) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, the patient experienced PARAESTHESIA (Tingling). On an unknown date, the patient experienced VACCINATION SITE WARMTH (A red ball swollen, it's warm on the site), HYPOAESTHESIA (Numb), PARAESTHESIA (Tingling on the arm), PAIN IN EXTREMITY (Pain in the arm), RASH MACULAR (Red spot) and VACCINATION SITE SWELLING (Red ball swollen, it's warm on the site). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (A red ball swollen, it's warm on the site), PARAESTHESIA (Tingling) and VACCINATION SITE SWELLING (Red ball swollen, it's warm on the site) outcome was unknown and HYPOAESTHESIA (Numb), PARAESTHESIA (Tingling on the arm), PAIN IN EXTREMITY (Pain in the arm) and RASH MACULAR (Red spot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: A red ball swollen, it's warm on the site; Red ball swollen, it's warm on the site; Tingling; Numb; Tingling on the arm; Pain in the arm; Red spot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (A red ball swollen, it's warm on the site), PARAESTHESIA (Tingling), HYPOAESTHESIA (Numb), PARAESTHESIA (Tingling on the arm) and PAIN IN EXTREMITY (Pain in the arm) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, the patient experienced PARAESTHESIA (Tingling). On an unknown date, the patient experienced VACCINATION SITE WARMTH (A red ball swollen, it's warm on the site), HYPOAESTHESIA (Numb), PARAESTHESIA (Tingling on the arm), PAIN IN EXTREMITY (Pain in the arm), RASH MACULAR (Red spot) and VACCINATION SITE SWELLING (Red ball swollen, it's warm on the site). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (A red ball swollen, it's warm on the site), PARAESTHESIA (Tingling) and VACCINATION SITE SWELLING (Red ball swollen, it's warm on the site) outcome was unknown and HYPOAESTHESIA (Numb), PARAESTHESIA (Tingling on the arm), PAIN IN EXTREMITY (Pain in the arm) and RASH MACULAR (Red spot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Occasionally, at the injection site my arm feels  slightly itchy; nausea; aching; Occasionally, at the injection site my arm feels sore; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Occasionally, at the injection site my arm feels  slightly itchy), NAUSEA (nausea), MYALGIA (aching) and VACCINATION SITE PAIN (Occasionally, at the injection site my arm feels sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Occasionally, at the injection site my arm feels  slightly itchy), NAUSEA (nausea), MYALGIA (aching) and VACCINATION SITE PAIN (Occasionally, at the injection site my arm feels sore). At the time of the report, VACCINATION SITE PRURITUS (Occasionally, at the injection site my arm feels  slightly itchy), NAUSEA (nausea), MYALGIA (aching) and VACCINATION SITE PAIN (Occasionally, at the injection site my arm feels sore) outcome was unknown.            Treatment information was not provided. List of concomitant medication were not given.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Non-significant Follow-up
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old received vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Fatigue, Feeling abnormal, Headache, Magnetic resonance imaging
Clinical narrative: keeps on having episodes of "slight forgetfulness"; episodes of tiredness; next couple of months, she noticed she is not being herself; headache set in from morning until middle of the night; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (keeps on having episodes of "slight forgetfulness"), MYALGIA (sore arm), FATIGUE (episodes of tiredness), HEADACHE (headache set in from morning until middle of the night) and FEELING ABNORMAL (next couple of months, she noticed she is not being herself) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS], NICOTINAMIDE (VITAMIN B3) and FISH OIL (FISH OIL OMEGA 3) for an unknown indication.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced MYALGIA (sore arm). On 26-Mar-2021, the patient experienced HEADACHE (headache set in from morning until middle of the night). On an unknown date, the patient experienced MEMORY IMPAIRMENT (keeps on having episodes of "slight forgetfulness"), FATIGUE (episodes of tiredness) and FEELING ABNORMAL (next couple of months, she noticed she is not being herself). At the time of the report, MEMORY IMPAIRMENT (keeps on having episodes of "slight forgetfulness"), MYALGIA (sore arm), FATIGUE (episodes of tiredness), HEADACHE (headache set in from morning until middle of the night) and FEELING ABNORMAL (next couple of months, she noticed she is not being herself) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal. On an unknown date, Magnetic resonance imaging: normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided.   This case was linked to MOD-2021-253136 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Myalgia
Clinical narrative: keeps on having episodes of "slight forgetfulness"; episodes of tiredness; next couple of months, she noticed she is not being herself; headache set in from morning until middle of the night; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (keeps on having episodes of "slight forgetfulness"), MYALGIA (sore arm), FATIGUE (episodes of tiredness), HEADACHE (headache set in from morning until middle of the night) and FEELING ABNORMAL (next couple of months, she noticed she is not being herself) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS], NICOTINAMIDE (VITAMIN B3) and FISH OIL (FISH OIL OMEGA 3) for an unknown indication.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced MYALGIA (sore arm). On 26-Mar-2021, the patient experienced HEADACHE (headache set in from morning until middle of the night). On an unknown date, the patient experienced MEMORY IMPAIRMENT (keeps on having episodes of "slight forgetfulness"), FATIGUE (episodes of tiredness) and FEELING ABNORMAL (next couple of months, she noticed she is not being herself). At the time of the report, MEMORY IMPAIRMENT (keeps on having episodes of "slight forgetfulness"), MYALGIA (sore arm), FATIGUE (episodes of tiredness), HEADACHE (headache set in from morning until middle of the night) and FEELING ABNORMAL (next couple of months, she noticed she is not being herself) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal. On an unknown date, Magnetic resonance imaging: normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided.   This case was linked to MOD-2021-253136 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Mass
Clinical narrative: Arm stayed red; hard lump; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm stayed red) and MASS (hard lump) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm stayed red) and MASS (hard lump). At the time of the report, ERYTHEMA (Arm stayed red) and MASS (hard lump) had resolved. Not Provided          No Concomitant medications were provided.   No treatment medications were provided.   This case was linked to MOD-2021-019262 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Fatigue, Magnetic resonance imaging, Myalgia
Clinical narrative: little bit tired, was wiped out; little bit of a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (little bit of a sore arm) and FATIGUE (little bit tired, was wiped out) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D NOS, NICOTINAMIDE (VITAMIN B3) and Fish oil Capsule for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced MYALGIA (little bit of a sore arm). On 25-Feb-2021, the patient experienced FATIGUE (little bit tired, was wiped out). At the time of the report, MYALGIA (little bit of a sore arm) and FATIGUE (little bit tired, was wiped out) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal. On an unknown date, Magnetic resonance imaging: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication was not provided.   This case was linked to MOD-2021-253112 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Myalgia, Pruritus
Clinical narrative: Arm hurts; Bad bruise; It just rubs; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Arm hurts), CONTUSION (Bad bruise) and PRURITUS (It just rubs) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009021A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2021, the patient experienced MYALGIA (Arm hurts), CONTUSION (Bad bruise) and PRURITUS (It just rubs). At the time of the report, MYALGIA (Arm hurts), CONTUSION (Bad bruise) and PRURITUS (It just rubs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphoedema, Product dose omission issue, Vaccination site pain, Vaccination site swelling, Vasculitis
Clinical narrative: Second Dose was not administered; Developed lymphedema; Immediate swelling at injection site; Immediate pain at the injection site; Vasculitis-type rash on lower extremities; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second Dose was not administered), VASCULITIS (Vasculitis-type rash on lower extremities), LYMPHOEDEMA (Developed lymphedema), VACCINATION SITE SWELLING (Immediate swelling at injection site) and VACCINATION SITE PAIN (Immediate pain at the injection site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2021, the patient experienced VASCULITIS (Vasculitis-type rash on lower extremities). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second Dose was not administered), LYMPHOEDEMA (Developed lymphedema), VACCINATION SITE SWELLING (Immediate swelling at injection site) and VACCINATION SITE PAIN (Immediate pain at the injection site). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second Dose was not administered), VASCULITIS (Vasculitis-type rash on lower extremities), LYMPHOEDEMA (Developed lymphedema) and VACCINATION SITE PAIN (Immediate pain at the injection site) outcome was unknown and VACCINATION SITE SWELLING (Immediate swelling at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication was reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Scratch, Vaccination site pruritus
Clinical narrative: Scratching/rubbing it produced a rash.; She felt intense itchiness on injection site; Scratching/rubbing it produced a rash/Rash s still present and worsens upon itching; This spontaneous case was reported by a consumer and describes the occurrence of SCRATCH (Scratching/rubbing it produced a rash.), VACCINATION SITE PRURITUS (She felt intense itchiness on injection site) and RASH (Scratching/rubbing it produced a rash/Rash s still present and worsens upon itching) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METFORMIN and GLIPIZIDE for an unknown indication.    On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jul-2021, the patient experienced RASH (Scratching/rubbing it produced a rash/Rash s still present and worsens upon itching). On an unknown date, the patient experienced SCRATCH (Scratching/rubbing it produced a rash.) and VACCINATION SITE PRURITUS (She felt intense itchiness on injection site). The patient was treated with BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOCAINE HYDROCHLORIDE (NEOSPORIN + BURN RELIEF) at an unspecified dose and frequency. At the time of the report, SCRATCH (Scratching/rubbing it produced a rash.), VACCINATION SITE PRURITUS (She felt intense itchiness on injection site) and RASH (Scratching/rubbing it produced a rash/Rash s still present and worsens upon itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reports that on 03 JUL 2021, she felt intense itchiness on the injection site and upon scratching/rubbing it produced a rash. The patient claims that the rash is still present and worsens upon itching.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: headaches; fatigues; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) and FATIGUE (fatigues) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches) and FATIGUE (fatigues). At the time of the report, HEADACHE (headaches) and FATIGUE (fatigues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided Concomitant medications were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Non Significant Follow up received on 12-JUL-2021 contains confirmation as 10-JUL-2021 from query to safety.
Sex: U
Vaccine: COVID19
Symptoms: Steroid therapy
Clinical narrative: Received steroid shot after 1st vaccine shot; This spontaneous case was reported by a consumer and describes the occurrence of STEROID THERAPY (Received steroid shot after 1st vaccine shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced STEROID THERAPY (Received steroid shot after 1st vaccine shot). At the time of the report, STEROID THERAPY (Received steroid shot after 1st vaccine shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.  No treatment medication was provided.
Age: 39.0
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Medication error
Clinical narrative: medication error; received 1st dose of the Moderna COVID-19 vaccine from a vial that had been first punctured on 07Jul2021 @ 3:42p with the syringe having been at room temperature approximately 24 hours when administered.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received 1st dose of the Moderna COVID-19 vaccine from a vial that had been first punctured on 07Jul2021 @ 3:42p with the syringe having been at room temperature approximately 24 hours when administered.) and MEDICATION ERROR (medication error) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received 1st dose of the Moderna COVID-19 vaccine from a vial that had been first punctured on 07Jul2021 @ 3:42p with the syringe having been at room temperature approximately 24 hours when administered.). On an unknown date, the patient experienced MEDICATION ERROR (medication error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received 1st dose of the Moderna COVID-19 vaccine from a vial that had been first punctured on 07Jul2021 @ 3:42p with the syringe having been at room temperature approximately 24 hours when administered.) and MEDICATION ERROR (medication error) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication were reported. Treatment medication was not provided.